Santonin

DB19377ApprovedWithdrawnSmall molecule

Santonin is a anthelmintic drug that was previously approved in the US to treat certain parasitic infections.

Mechanism: Pharmacologically active on Nuclear receptor subfamily 1 group I member 2 and Nuclear receptor subfamily 1 group I member 3
Curator reviewed

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Santonin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.